Entera Bio (ENTX) Earnings Date & Reports

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ENTX is expected to report earnings to rise 28.57% to -9 cents per share on August 07

Q2'26

Est.

$-0.09

Q1'26

Beat

by $0.04

Q4'25

Beat

by $0.05

Q3'25

Beat

by $0.16

Q2'25

Beat

by $0.05

The last earnings report on May 08 showed earnings per share of -7 cents, beating the estimate of -10 cents. With 51.01K shares outstanding, the current market capitalization sits at 59.64M.

View a ticker or compare two or three

Compare

ENTX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ENTX